Tullika Garg1,2, Amanda J Young3,4, Maureen O'Keeffe-Rosetti5, Carmit K McMullen5, Matthew E Nielsen5,6,7,8, H Lester Kirchner3,4, Terrence E Murphy9. 1. Department of Urology, Geisinger, Danville, Pennsylvania. 2. Department of Epidemiology and Health Services Research, Geisinger, Danville, Pennsylvania. 3. Biostatistics Core, Geisinger, Danville, Pennsylvania. 4. Biomedical and Translational Informatics Institute, Geisinger, Danville, Pennsylvania. 5. Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. 6. Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 7. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 8. Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 9. Section of Geriatrics, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Abstract
BACKGROUND: Multiple chronic conditions (MCC) are common among older patients with cancer; however, the exclusion of these patients from clinical trials has resulted in scarce knowledge concerning outcomes, resulting in variations in treatment. Superficial bladder cancer (SBC) disproportionately affects older adults, yet to the authors' knowledge few studies to date have examined whether treatment improves long-term survival. In the current study, the authors evaluated the association between treatment of SBC and 10-year mortality in medically complex older adults. METHODS: The authors identified 1800 older (aged ≥60 years) patients with SBC (American Joint Committee on Cancer stage ≤I) from 2 community-based health systems who received treatment (bladder instillation and/or transurethral resection) or observation. Cox proportional hazards regression was performed adjusting for age, sex, race, health system, stage of disease/grade, and MCC (≥2 baseline chronic conditions). Propensity score analysis using stabilized inverse probability of treatment weights was used to compare 10-year mortality in the 2 treatment groups with adjustment for covariates. RESULTS: Overall, 1485 patients (82.5%) and 315 patients (17.5%) received treatment and observation, respectively. In unweighted multivariable analysis, treatment was associated with a 30% reduction in death (adjusted hazard ratio [HR], 0.70; 95% confidence interval [95% CI], 0.58-0.85 [P<.01]) and MCC with a 72% increase in death (adjusted HR, 1.72; 95% CI, 1.44-2.05 [P<.01]). Weighted analysis with adjustment (doubly robust) also demonstrated a survival benefit for treatment (adjusted HR, 0.66; 95% CI, 0.52-0.84 [P<.01]). CONCLUSIONS: The results of the current study demonstrated a clinically meaningful association between cancer treatment and survival benefit in older, medically complex patients with SBC, even after adjustment for medical complexity. These data provide a foundation for future work aimed at personalizing the treatment guidance of older patients with cancer with MCC.
BACKGROUND: Multiple chronic conditions (MCC) are common among older patients with cancer; however, the exclusion of these patients from clinical trials has resulted in scarce knowledge concerning outcomes, resulting in variations in treatment. Superficial bladder cancer (SBC) disproportionately affects older adults, yet to the authors' knowledge few studies to date have examined whether treatment improves long-term survival. In the current study, the authors evaluated the association between treatment of SBC and 10-year mortality in medically complex older adults. METHODS: The authors identified 1800 older (aged ≥60 years) patients with SBC (American Joint Committee on Cancer stage ≤I) from 2 community-based health systems who received treatment (bladder instillation and/or transurethral resection) or observation. Cox proportional hazards regression was performed adjusting for age, sex, race, health system, stage of disease/grade, and MCC (≥2 baseline chronic conditions). Propensity score analysis using stabilized inverse probability of treatment weights was used to compare 10-year mortality in the 2 treatment groups with adjustment for covariates. RESULTS: Overall, 1485 patients (82.5%) and 315 patients (17.5%) received treatment and observation, respectively. In unweighted multivariable analysis, treatment was associated with a 30% reduction in death (adjusted hazard ratio [HR], 0.70; 95% confidence interval [95% CI], 0.58-0.85 [P<.01]) and MCC with a 72% increase in death (adjusted HR, 1.72; 95% CI, 1.44-2.05 [P<.01]). Weighted analysis with adjustment (doubly robust) also demonstrated a survival benefit for treatment (adjusted HR, 0.66; 95% CI, 0.52-0.84 [P<.01]). CONCLUSIONS: The results of the current study demonstrated a clinically meaningful association between cancer treatment and survival benefit in older, medically complex patients with SBC, even after adjustment for medical complexity. These data provide a foundation for future work aimed at personalizing the treatment guidance of older patients with cancer with MCC.
Authors: Michele Jonsson Funk; Daniel Westreich; Chris Wiesen; Til Stürmer; M Alan Brookhart; Marie Davidian Journal: Am J Epidemiol Date: 2011-03-08 Impact factor: 4.897
Authors: Sun Hee Rim; Gery P Guy; K Robin Yabroff; Kathleen A McGraw; Donatus U Ekwueme Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2016-10-06 Impact factor: 2.217
Authors: Maria Pisu; Andres Azuero; Karina I Halilova; Courtney P Williams; Kelly M Kenzik; Elizabeth A Kvale; Grant R Williams; Karen Meneses; Margaret Sullivan; Supriya Kumar Yagnik; Hans-Peter Goertz; Gabrielle B Rocque Journal: Cancer Date: 2017-12-18 Impact factor: 6.860
Authors: Anne M Suskind; Louise C Walter; Chengshi Jin; John Boscardin; Saunak Sen; Matthew R Cooperberg; Emily Finlayson Journal: BJU Int Date: 2016-01-17 Impact factor: 5.588
Authors: Shawna V Hudson; Suzanne M Miller; Jennifer Hemler; Aneesah McClinton; Kevin C Oeffinger; Alfred Tallia; Benjamin F Crabtree Journal: Transl Behav Med Date: 2012-09 Impact factor: 3.046
Authors: Carol E DeSantis; Chun Chieh Lin; Angela B Mariotto; Rebecca L Siegel; Kevin D Stein; Joan L Kramer; Rick Alteri; Anthony S Robbins; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2014-06-01 Impact factor: 508.702
Authors: Tullika Garg; Courtney A Polenick; Nancy Schoenborn; Jane Jih; Alexandra Hajduk; Melissa Y Wei; Jaime Hughes Journal: J Clin Med Date: 2021-05-14 Impact factor: 4.964